Clinical Observation of Improving Uremia Combined with Hyperparathyroidism by Treatment of Hemoperfusion Series Coupling Hemodiafiltration

AN Shu-qiang,YANG Qian,SHI Chang-sheng,CUI Ling,JIA Xiao-juan
DOI: https://doi.org/10.3969/j.issn.1002-3429.2013.02.036
2013-01-01
Abstract:Objective To discuss the curative effect of improvement of uremia combined with hyperparathyroidism by hemoperfusion(HP) series coupling hemodiafiltration(HDF) treatment.Methods Sixty patients with uremia combined with secondary hyperparathyroidism during August 2008 and August 2011 were randomly divided into group A and group B.Group A was treated with high-flux hemodialysis(HFHD);while group B was treated with hemoperfusion(HP) series coupling hemodiafiltration(HDF).The parathyroid hormone(PTH),blood urea nitrogen(BUN),serum creatinine(SCr),serum calcium(Ca2+),phosphorus(P3+),hemoglobin(Hb),hematocrit(HCT),blood pressure and erythropoietin dosage of the two groups were detected before and after the first treatment,and at the12th week after treatment.Indexes of improving secondary hyperparathyroidism of the two groups were also observed.Results The differences of the two groups were not statistically significant in PTH,Hb,HCT,BUN,SCr,Ca2+,P3+,the first week dose of erythropoietin and blood pressure(P0.05);After first treatment,the differences were statistically significant in PTH and renal function(P0.05);Before the last treatment there were statistically significant in PTH,Hb,HCT,BUN,SCr,Ca2+,P3+,the 12th week dose of erythropoietin and blood pressure(P0.05);After the last treatment the difference in PTH was statistically significant(P0.05).Conclusion The method of HP series coupling HDF can effectively improve indexes of uremia combined with secondary hyperparathyroidism.
What problem does this paper attempt to address?